Endoscopic Devices - Czechia | Statista Market Forecast

In Czechia, revenue in the Endoscopic Devices market market is projected to reach US$118.90m in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 7.51%, which will result in a market volume of US$170.80m by 2029.
In a global context, the majority of revenue will be generated the United States, amounting to US$10.39bn in 2024.
Czechia's healthcare sector is increasingly adopting advanced endoscopic devices, driven by a growing emphasis on minimally invasive procedures and improved patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Czechia is witnessing moderate growth, influenced by factors such as increasing healthcare investments, advancements in technology, and a rising demand for minimally invasive procedures among patients and healthcare providers.

Customer preferences: In Czechia, there is a growing preference for endoscopic procedures, largely driven by an aging population and an increased focus on preventive healthcare. Patients are increasingly favoring minimally invasive options due to shorter recovery times and reduced hospital stays, reflecting a cultural shift towards proactive health management. Additionally, younger demographics are becoming more informed about their treatment choices, leading to heightened demand for advanced endoscopic technologies that promise enhanced safety and effectiveness. This trend underscores the importance of continuous innovation in the endoscopic devices market.

Trends in the market: In Czechia, the Endoscopic Devices Market is experiencing a significant shift towards the adoption of advanced imaging technologies, such as high-definition and 3D endoscopes, which enhance visualization during procedures. Concurrently, there is a rising interest in robotic-assisted endoscopy, driven by the demand for precision and improved patient outcomes. The aging population is a key factor influencing this trend, as more individuals seek minimally invasive options. As healthcare providers prioritize patient-centered care, industry stakeholders must invest in innovation and training to keep pace with evolving needs and preferences.

Local special circumstances: In Czechia, the Endoscopic Devices Market is influenced by the country's robust healthcare infrastructure and strong emphasis on preventive care, driven by a well-educated population that values advanced medical technologies. The Czech government supports healthcare innovation through funding and regulatory frameworks that facilitate swift adoption of new technologies. Additionally, local manufacturers are collaborating with international firms, fostering knowledge exchange and boosting product development. Cultural attitudes toward minimally invasive procedures further propel the demand for endoscopic solutions, enhancing patient acceptance and satisfaction.

Underlying macroeconomic factors: The Endoscopic Devices Market in Czechia is shaped by several macroeconomic factors, including national economic stability, healthcare expenditure, and demographic trends. A strong GDP growth and low unemployment rates contribute to increased public and private spending on healthcare technologies. The Czech government’s fiscal policies prioritize health innovation, resulting in substantial investments in medical infrastructure. Furthermore, the rising prevalence of chronic diseases and an aging population intensify the need for minimally invasive procedures. Global economic trends, such as advancements in medical technology and international collaborations, also enhance market competitiveness and product innovation, driving the growth of endoscopic solutions in the region.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.